This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| NMC HEALTH PLC | 2,298.0 | 6.5% |
| STANDARD LIFE ABERDEEN PLC | 250.7 | 4.2% |
| BRITISH LAND CO PLC | 517.2 | 4.1% |
| LAND SECURITIES GROUP PLC | 784.6 | 3.3% |
| SMURFIT KAPPA GROUP PLC | 2,490.0 | 3.2% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| BRITISH AMERICAN TOBACCO PLC | 2832.0 | -4.4% |
| JUST EAT PLC | 756.0 | -2.1% |
| FERGUSON PLC | 5884.0 | -1.7% |
| STANDARD CHARTERED PLC | 606.8 | -1.2% |
| BURBERRY GROUP PLC | 2109.0 | -1.2% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,090 | -0.1% | -6.9% |
| DOW JONES INDUS. AVG | 25,778 | -0.5% | -1.1% |
| DAX INDEX | 11,730 | 0.6% | -6.4% |
| NIKKEI 225 | 20,479 | 0.1% | -10.2% |
| S&P/ASX 200 INDEX | 6,501 | 0.5% | 3.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 55.58 | 1.18% |
| Brent Crude (ICE) | USD/bbl. | 60.06 | 0.92% |
| Gold Spot | USD/t oz. | 1,541 | -0.1% |
| Copper (Comex) | USd/lb. | 256 | 0.3% |
Click graph to enlarge
UK 100 called to open flat this morning at 7082. This comes on the back of a rollercoaster trading session in the US which saw the Dow Jones swing from positive to negative by close. Stocks in Asia had a more positive trading session, all major bourses closing the day in the green (With the exception of the Hang Seng) could this positive sentiment spill into European trading sessions? US futures are already positive ahead of today's trading. Oil picked back up to the $60 a barrel level overnight. Gold continued to rally through yesterdays US session, seeing the traditional safe haven settle at $1539.
AstraZeneca announced that the FDA has granted Orphan Drug Designation to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis.
Astra also announced Breztri Aerosphere Phase III ETHOS trial met its primary endpoint in chronic obstructive pulmonary disease.
Anglo American announces their rough diamond sales values for De Beer’s 7th sales cycle of 2019, amounting to $280m.
Diploma have announced trading has remained in line with expectations, with good underlying growth in life sciences and controls. On track for another good performance in FY 2019.
Petrofac H1 2019 profit -8.7% because of an ongoing probe into its contract dealings in Saudi Arabia and Iraq. Its estimated it has lost out on $10bn worth of contracts globally due to the investigation by Britain's Serious Fraud Office which led to the conviction of its former head of sales on 11 counts of bribery related to Iraqi and Saudi contracts. New orders of $2bn (2018: $3.3bn).
Thomas Cook has given an update on the implementation of their proposed recapitalisation. Fosun will contribute £450m of new money to the group and will acquire at least 75% of the equity of the group tour operator and 25% of the group airline. Implementation of this commitment is targeted for early October 2019.
WH Smith announced outcome for year to Aug 31st is to be in line with expectations.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Meggitt Downgraded to sell by Societe Generale (Bloomberg: 9 Buys / 6 Holds / 4 Sells; Average 12m price target 598.25p)
German Consumer Confidence (7am)
German 10 Year Bond Auction (10.40am)
US MBA Mortgage Applications (12pm)
EIA Crude Oil Stocks (3.30pm)
Diploma, Petrofac, WH Smith
Diploma, Petrofac, WH Smith
Grafton Group
St James place - 2%
Autotrader - 0.9%
Hammerson - 5.1%
Plus 500 - 3.1%
Centamin - 2.4%
(Full list available on Week in advance)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.